Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
1
|
Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease.
|
N Engl J Med
|
2009
|
17.17
|
2
|
2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
|
Eur Heart J
|
2014
|
9.73
|
3
|
Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial.
|
Lancet
|
2013
|
4.34
|
4
|
Meta-analysis of positron emission tomographic and computed tomographic imaging in detecting mediastinal lymph node metastases in nonsmall cell lung cancer.
|
Ann Thorac Surg
|
2005
|
2.80
|
5
|
Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery.
|
N Engl J Med
|
2011
|
2.65
|
6
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement.
|
J Am Coll Cardiol
|
2012
|
2.44
|
7
|
Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study.
|
J Am Coll Cardiol
|
2013
|
2.41
|
8
|
Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
|
Circulation
|
2010
|
2.40
|
9
|
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
|
J Am Coll Cardiol
|
2010
|
2.24
|
10
|
Relationship between the logistic EuroSCORE and the Society of Thoracic Surgeons Predicted Risk of Mortality score in patients implanted with the CoreValve ReValving system--a Bern-Rotterdam Study.
|
Am Heart J
|
2010
|
1.87
|
11
|
Clinical outcomes after transcatheter aortic valve replacement using valve academic research consortium definitions: a weighted meta-analysis of 3,519 patients from 16 studies.
|
J Am Coll Cardiol
|
2012
|
1.80
|
12
|
Incidence, predictors and outcomes of incomplete revascularization after percutaneous coronary intervention and coronary artery bypass grafting: a subgroup analysis of 3-year SYNTAX data.
|
Eur J Cardiothorac Surg
|
2011
|
1.77
|
13
|
Transcatheter aortic valve replacement in Europe: adoption trends and factors influencing device utilization.
|
J Am Coll Cardiol
|
2013
|
1.76
|
14
|
Economic outcomes of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with left main or three-vessel coronary artery disease: one-year results from the SYNTAX trial.
|
Catheter Cardiovasc Interv
|
2011
|
1.71
|
15
|
2014 ESC/EACTS guidelines on myocardial revascularization.
|
Rev Esp Cardiol (Engl Ed)
|
2015
|
1.69
|
16
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
|
Ann Thorac Surg
|
2012
|
1.59
|
17
|
The new EuroSCORE II does not improve prediction of mortality in high-risk patients undergoing cardiac surgery: a collaborative analysis of two European centres.
|
Eur J Cardiothorac Surg
|
2013
|
1.55
|
18
|
Proper treatment selection may improve survival in patients with clinical early-stage nonsmall cell lung cancer.
|
Ann Thorac Surg
|
2005
|
1.54
|
19
|
Charlson comorbidity index as a predictor of long-term outcome after surgery for nonsmall cell lung cancer.
|
Eur J Cardiothorac Surg
|
2005
|
1.54
|
20
|
Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
1.50
|
21
|
Population characteristics, treatment assignment and survival of patients with aortic stenosis referred for percutaneous valve replacement.
|
EuroIntervention
|
2008
|
1.47
|
22
|
Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease.
|
JACC Cardiovasc Interv
|
2013
|
1.42
|
23
|
The European Association for Cardio-Thoracic Surgery (EACTS) database: an introduction.
|
Eur J Cardiothorac Surg
|
2013
|
1.42
|
24
|
Do we need separate risk stratification models for hospital mortality after heart valve surgery?
|
Ann Thorac Surg
|
2008
|
1.41
|
25
|
Impact of methodology and assumptions in a cost-effectiveness analysis on transcatheter aortic valve replacement.
|
J Thorac Cardiovasc Surg
|
2013
|
1.38
|
26
|
Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications.
|
Eur Heart J
|
2012
|
1.29
|
27
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
|
J Thorac Cardiovasc Surg
|
2012
|
1.28
|
28
|
Patient outcome after aortic valve replacement with a mechanical or biological prosthesis: weighing lifetime anticoagulant-related event risk against reoperation risk.
|
J Thorac Cardiovasc Surg
|
2009
|
1.22
|
29
|
Preoperative and operative predictors of delirium after cardiac surgery in elderly patients.
|
Eur J Cardiothorac Surg
|
2012
|
1.22
|
30
|
Paravalvular leak after transcatheter aortic valve replacement: the new Achilles' heel? A comprehensive review of the literature.
|
J Am Coll Cardiol
|
2013
|
1.11
|
31
|
The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.
|
Am Heart J
|
2006
|
1.10
|
32
|
2014 ESC/EACTS guidelines on myocardial revascularization.
|
EuroIntervention
|
2015
|
1.08
|
33
|
EACTS guidelines for the use of patient safety checklists.
|
Eur J Cardiothorac Surg
|
2012
|
1.07
|
34
|
Complex coronary anatomy in coronary artery bypass graft surgery: impact of complex coronary anatomy in modern bypass surgery? Lessons learned from the SYNTAX trial after two years.
|
J Thorac Cardiovasc Surg
|
2011
|
1.07
|
35
|
A systematic review of risk prediction in adult cardiac surgery: considerations for future model development.
|
Eur J Cardiothorac Surg
|
2013
|
1.06
|
36
|
Factors associated with perioperative complications and long-term results after pulmonary resection for primary carcinoma of the lung.
|
Eur J Cardiothorac Surg
|
2003
|
1.05
|
37
|
Current concepts on coronary revascularization in diabetic patients.
|
Eur Heart J
|
2011
|
1.05
|
38
|
Guideline for the surgical treatment of atrial fibrillation.
|
Eur J Cardiothorac Surg
|
2013
|
1.03
|
39
|
Long-term survival after non-small cell lung cancer surgery: development and validation of a prognostic model with a preoperative and postoperative mode.
|
J Thorac Cardiovasc Surg
|
2006
|
0.98
|
40
|
Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome.
|
Ann Thorac Surg
|
2011
|
0.98
|
41
|
Surgery in current therapy for infective endocarditis.
|
Vasc Health Risk Manag
|
2011
|
0.97
|
42
|
Predicting prognosis in cardiac surgery: a prophecy?
|
Eur J Cardiothorac Surg
|
2012
|
0.96
|
43
|
What the cardiothoracic surgeon wants to know from the radiologist: from X-ray reporting to imaging consultancy and Heart Team membership.
|
Pediatr Radiol
|
2015
|
0.95
|
44
|
Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population.
|
Ann Thorac Surg
|
2003
|
0.95
|
45
|
The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease.
|
Eur Heart J
|
2013
|
0.94
|
46
|
Cost-effectiveness of transcatheter valvular interventions: economic challenges.
|
EuroIntervention
|
2013
|
0.94
|
47
|
Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications.
|
Eur Heart J
|
2012
|
0.93
|
48
|
Survival after pathological stage IA nonsmall cell lung cancer: tumor size matters.
|
Ann Thorac Surg
|
2005
|
0.93
|
49
|
Non-inferiority study design: lessons to be learned from cardiovascular trials.
|
Eur Heart J
|
2012
|
0.93
|
50
|
The SYNTAX score and its clinical implications.
|
Heart
|
2013
|
0.92
|
51
|
Allografts for aortic valve or root replacement: insights from an 18-year single-center prospective follow-up study.
|
Eur J Cardiothorac Surg
|
2007
|
0.91
|
52
|
Costs for surgical aortic valve replacement according to preoperative risk categories.
|
Ann Thorac Surg
|
2013
|
0.87
|
53
|
The 4th European Association for Cardio-Thoracic Surgery adult cardiac surgery database report.
|
Interact Cardiovasc Thorac Surg
|
2011
|
0.86
|
54
|
Long-term follow-up and quality of life after closure of ventricular septal defect in adults.
|
Eur J Cardiothorac Surg
|
2007
|
0.86
|
55
|
Surgical treatment of active native aortic valve endocarditis with allografts and mechanical prostheses.
|
Ann Thorac Surg
|
2009
|
0.86
|
56
|
Coronary artery bypass grafting: Part 1--the evolution over the first 50 years.
|
Eur Heart J
|
2013
|
0.85
|
57
|
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance.
|
Catheter Cardiovasc Interv
|
2012
|
0.85
|
58
|
The role of EuroSCORE II in 21st century cardiac surgery practice.
|
Eur J Cardiothorac Surg
|
2012
|
0.84
|
59
|
The SURTAVI model: proposal for a pragmatic risk stratification for patients with severe aortic stenosis.
|
EuroIntervention
|
2012
|
0.83
|
60
|
[2014 ESC/EACTS Guidelines on myocardial revascularization].
|
Kardiol Pol
|
2014
|
0.83
|
61
|
Cost effectiveness of coronary revascularisation.
|
EuroIntervention
|
2010
|
0.81
|
62
|
A crucial factor in shared decision making: the team approach.
|
Lancet
|
2011
|
0.81
|
63
|
Costs of transcatheter versus surgical aortic valve replacement in intermediate-risk patients.
|
Ann Thorac Surg
|
2012
|
0.81
|
64
|
Appropriate coronary artery bypass grafting use in the percutaneous coronary intervention era: are we finally making progress?
|
Semin Thorac Cardiovasc Surg
|
2012
|
0.81
|
65
|
Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries.
|
JACC Cardiovasc Interv
|
2012
|
0.81
|
66
|
Usefulness of microsimulation to translate valve performance into patient outcome: patient prognosis after aortic valve replacement with the Carpentier-Edwards supra-annular valve.
|
J Thorac Cardiovasc Surg
|
2007
|
0.80
|
67
|
Transcatheter aortic valve implantation after PARTNER: what is up next?
|
EuroIntervention
|
2010
|
0.79
|
68
|
How to assess risks of valve surgery: quality, implementation and future of risk models.
|
Heart
|
2009
|
0.79
|
69
|
Complexity of coronary vasculature predicts outcome of surgery for left main disease.
|
Ann Thorac Surg
|
2009
|
0.77
|
70
|
Subgroup analyses in trial reports comparing percutaneous coronary intervention with coronary artery bypass surgery.
|
JAMA
|
2013
|
0.77
|
71
|
Drug-eluting stent implantation for coronary artery disease: current stents and a comparison with bypass surgery.
|
Curr Opin Pharmacol
|
2012
|
0.76
|
72
|
Virtual reality 3D echocardiography in the assessment of tricuspid valve function after surgical closure of ventricular septal defect.
|
Cardiovasc Ultrasound
|
2007
|
0.75
|
73
|
Surgical implications of coronary arterial anatomy in adults with congenital cardiac disease.
|
Open Cardiovasc Med J
|
2008
|
0.75
|
74
|
Surgical or transcatheter mitral valve intervention: complex disease requires complex decisions.
|
EuroIntervention
|
2014
|
0.75
|
75
|
Long-term survival of young patients with coronary artery disease is best realized through surgical revascularization with mammary arteries.
|
J Am Coll Cardiol
|
2013
|
0.75
|
76
|
Invited commentary.
|
Ann Thorac Surg
|
2012
|
0.75
|
77
|
Single-centre experience with mitral valve repair in asymptomatic patients with severe mitral valve regurgitation.
|
Interact Cardiovasc Thorac Surg
|
2013
|
0.75
|
78
|
Carriage of reduced-function CYP2C19 allele among patients treated with clopidogrel.
|
JAMA
|
2011
|
0.75
|
79
|
Nonrandomized data on drug-eluting stents compared with coronary bypass surgery caution with interpretation.
|
J Am Coll Cardiol
|
2011
|
0.75
|
80
|
Off-pump or on-pump coronary-artery bypass grafting.
|
N Engl J Med
|
2012
|
0.75
|
81
|
Details in a meta-analysis comparing mitral valve repair to replacement for ischemic regurgitation.
|
Eur J Cardiothorac Surg
|
2012
|
0.75
|
82
|
Outcome after aortic valve replacement in young adults: is patient profile more important than prosthesis type?
|
J Heart Valve Dis
|
2006
|
0.75
|
83
|
Hierarchical testing of composite endpoints: applying the win ratio to percutaneous coronary intervention versus coronary artery bypass grafting in the SYNTAX trial.
|
EuroIntervention
|
2017
|
0.75
|
84
|
Towards excellence in revascularization for left main coronary artery disease.
|
Curr Opin Cardiol
|
2012
|
0.75
|
85
|
Arterial grafting and complete revascularization: challenge or compromise?
|
Curr Opin Cardiol
|
2013
|
0.75
|
86
|
Multivessel coronary artery disease: quantifying how recent trials should influence clinical practice.
|
Expert Rev Cardiovasc Ther
|
2013
|
0.75
|
87
|
Coronary artery bypass grafting: the past, present, and the future.
|
Eur Heart J
|
2013
|
0.75
|
88
|
Angiographic outcomes following stenting or coronary artery bypass surgery of the left main coronary artery: fifteen-month outcomes from the synergy between PCI with TAXUS express and cardiac surgery left main angiographic substudy (SYNTAX-LE MANS).
|
EuroIntervention
|
2011
|
0.75
|
89
|
Drug-eluting stent-supported percutaneous coronary intervention in high risk patients refused cardiac surgery.
|
EuroIntervention
|
2005
|
0.75
|
90
|
A meta-analysis on clinical outcomes after transaortic transcatheter aortic valve implantation by the Heart Team.
|
EuroIntervention
|
2017
|
0.75
|
91
|
The bright future of cardiothoracic and vascular surgery: the role of EACTS.
|
Eur J Cardiothorac Surg
|
2013
|
0.75
|
92
|
Intraoperative real time three-dimensional transesophageal echocardiographic measurement of hemodynamic, anatomic and functional changes after aortic valve replacement.
|
Echocardiography
|
2008
|
0.75
|
93
|
Tools and Techniques--Clinical: the transaortic approach through a mini-sternotomy using the self-expandable CoreValve Revalving System.
|
EuroIntervention
|
2013
|
0.75
|
94
|
VARC endpoint definition compliance rates in contemporary transcatheter aortic valve implantation studies.
|
EuroIntervention
|
2016
|
0.75
|
95
|
Acute dehiscence of a valve prosthesis 5 years after implantation.
|
Int J Cardiol
|
2007
|
0.75
|
96
|
Management of elderly patients with aortic valve disease.
|
Nat Clin Pract Cardiovasc Med
|
2008
|
0.75
|
97
|
Failing surgical bioprosthesis in aortic and mitral position.
|
EuroIntervention
|
2013
|
0.75
|
98
|
Emergency surgery due to haematoma in a case of left atrial myxoma.
|
Heart Lung Circ
|
2006
|
0.75
|